Company intelligence / Profile preview
tiakis Biotech AG
Kiel, Schleswig-Holstein, Germanytiakis.bio ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
tiakis Biotech AG develops Tiprelestat, a recombinant human Elafin protein with anti-inflammatory and tissue-protective properties. Tiprelestat has shown safety and initial efficacy signals in hospitalized COVID‑19 patients and received positive FDA feedback for a planned Phase II trial in pulmonary arterial hypertension. The company’s approach targets neutrophil-driven inflammation to prevent severe organ damage after invasive surgery or due to vascular diseases. Clinical data indicate good tolerability and potential reduction of oxygen support days in treated patients compared to placebo.
- Therapeutic areas
- ImmunologyCardiovascularDermatologyInfectious Diseases
- Modalities
- Recombinant proteins (notably human recombinant Elafin/Tiprelestat)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with Stanford University for the ATHENA trialparticipation in federal/state R&D programs in Germany
Beyond the preview
Go deeper on tiakis Biotech AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tiakis Biotech AG.